Transition Services AgreementTransition Services Agreement • December 23rd, 2008 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledDecember 23rd, 2008 Company IndustryThis Transition Services Agreement (this “Agreement”) is entered into as of December 18, 2008, by and between PDL BioPharma, Inc., a Delaware corporation (“PDL”), and Facet Biotech Corporation, a Delaware corporation (“Facet”), each a “Party” and together, the “Parties”. Capitalized terms not defined herein shall have the meaning set forth in that certain Separation and Distribution Agreement dated as of December 17, 2008 by and between the Parties, as amended or otherwise modified from time to time (the “Separation Agreement”). This Agreement shall be effective on the Distribution Date, as defined in the Separation Agreement.
Transition Services AgreementTransition Services Agreement • December 18th, 2008 • Facet Biotech Corp • Pharmaceutical preparations
Contract Type FiledDecember 18th, 2008 Company IndustryThis Transition Services Agreement (this “Agreement”) is entered into as of December 18, 2008, by and between PDL BioPharma, Inc., a Delaware corporation (“PDL”), and Facet Biotech Corporation, a Delaware corporation (“Facet”), each a “Party” and together, the “Parties”. Capitalized terms not defined herein shall have the meaning set forth in that certain Separation and Distribution Agreement dated as of December 17, 2008 by and between the Parties, as amended or otherwise modified from time to time (the “Separation Agreement”). This Agreement shall be effective on the Distribution Date, as defined in the Separation Agreement.
Transition Services AgreementTransition Services Agreement • November 12th, 2008 • Facet Biotech Corp • Pharmaceutical preparations
Contract Type FiledNovember 12th, 2008 Company IndustryThis Transition Services Agreement (this “Agreement”) is entered into as of [ ], 2008, by and between PDL BioPharma, Inc., a Delaware corporation (“PDL”), and Facet Biotech Corporation, a Delaware corporation (“Facet”), each a “Party” and together, the “Parties”. Capitalized terms not defined herein shall have the meaning set forth in that certain Separation and Distribution Agreement dated as of the date hereof by and between the Parties, as amended or otherwise modified from time to time (the “Separation Agreement”). This Agreement shall be effective on the Distribution Date, as defined in the Separation Agreement.